Cover Image

Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Mark Ellison, Emily Hutton, Lynn Webster, Phil Skolnick
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	The Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone
by: Alessandra Cipriano, et al.
Published: (2024)

Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto‐Injector Versus Intranasal Naloxone
by: Alessandra Cipriano, et al.
Published: (2025)

Comment on: Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
by: Phil Skolnick
Published: (2024)

Can Intranasal Nalmefene Reduce the Number of Opioid Overdose Deaths?
by: Edward M. Sellers, et al.
Published: (2024)

Intranasal Naloxone During Recurrent Exercise in Individuals with Type‐1 Diabetes Mellitus: Evaluation of the Clinical Predictors of Pharmacokinetics and Exposure–Response
by: Omar N. Al Yacoub, et al.
Published: (2025)

Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male Volunteers
by: Jean Bousquet, et al.
Published: (2025)

Bioequivalence Assessment for Intranasal Rapid‐Acting Drug Products
by: Zhijun (Kevin) Wang, et al.
Published: (2026)

Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective
by: Celine M. Laffont, et al.
Published: (2025)

Intranasal bumetanide in heart failure: Innovation ahead of evidence
by: Zehra Sadia, et al.
Published: (2025)

Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens
by: Monique P. H. Tillemans, et al.
Published: (2024)

Single‐Dose Pharmacokinetics of Intranasal Levetiracetam in Healthy Dogs
by: Jessica L. Wagner, et al.
Published: (2026)

FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose
by: Srikanth C. Nallani, et al.
Published: (2024)

Comparing the Efficacy of Various Insulin Types: Pharmacokinetic and Pharmacodynamic Modeling of Glucose Clamp Effects in Healthy Volunteers
by: Yi Chien Chang, et al.
Published: (2025)

Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine–Naloxone With a Focus on the Unhoused Population
by: David F Lehmann, et al.
Published: (2026)

A Phase 1 Randomized, Double‐Blind, Placebo‐Controlled Single and Multiple Ascending Dose Study of DISC‐3405, a Novel Recombinant Humanized Monoclonal Antibody Targeting TMPRSS6, in Adult Healthy Volunteers
by: Guowen Liu, et al.
Published: (2026)

Comparison of Anti‐Hepatitis A Antibody Pharmacokinetics in Healthy Australian Subjects Receiving Standard or Weight‐Based Dosing of Polyvalent Immunoglobulin
by: Megan K Young, et al.
Published: (2024)

Bioequivalence of Meloxicam Nanocrystal Injection in Healthy Chinese Volunteers
by: Shengling Hu, et al.
Published: (2024)

Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
by: Sheng He, et al.
Published: (2024)

Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
by: Pamela Navarro‐Gonzales, et al.
Published: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
by: Zhaoyu Wang, et al.
Published: (2024)

Correction to: Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
Published: (2024)

Population Pharmacokinetics of Dapoxetine in Healthy Chinese Male Subjects
by: Libin Pu, et al.
Published: (2025)

Pharmacokinetics of Atorvastatin and Metformin after Coadministration with Islatravir in Healthy Adults
by: Jacqueline B. McCrea, et al.
Published: (2024)

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
by: Kenza Abouir, et al.
Published: (2024)

Pharmacokinetics, Receptor Occupancy, and Pharmacodynamics of Obexelimab Following Intravenous Administration in Adult Healthy Volunteers and in Patients With Rheumatoid Arthritis
by: Xiaodong Wang, et al.
Published: (2025)

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers
by: Shruti M. Raja, et al.
Published: (2024)

Clinical Assessment of the Drug–Drug Interaction Potential of Omaveloxolone in Healthy Adult Participants
by: Hamim Zahir, et al.
Published: (2025)

Population Pharmacokinetics of Oral Gecacitinib in Healthy Subjects and Patients with Autoimmune and Inflammatory Diseases
by: Qingheng Meng, et al.
Published: (2026)

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers
by: Gang Chen, et al.
Published: (2025)

Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers
by: Eugenio Mercuri, et al.
Published: (2026)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
by: Pan Luo, et al.
Published: (2026)

Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
by: Kejia Fu, et al.
Published: (2026)

Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers
by: Marella Cornelia Elizabeth van Ruissen, et al.
Published: (2025)

Pharmacokinetics and Bioequivalence Evaluation of Trazodone Hydrochloride Sustained‐Release Tablets in Healthy Chinese Volunteers
by: Jingyan Wang, et al.
Published: (2024)

Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip
by: Kuan‐Ju Lin, et al.
Published: (2024)

Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers
by: Jin Yu, et al.
Published: (2024)

Reply to “Translational Modeling as a Tool to Evaluate the Effectiveness of Nalmefene in a Community Setting: A Critical Perspective”
by: Zhihua Li, et al.
Published: (2025)

Limited Sampling Strategy for Predicting the Area under Plasma Concentration–Time Curve of Nadolol in Healthy Subjects
by: Shingen Misaka, et al.
Published: (2024)

Pharmacokinetics, Safety, and Tolerability of Anti‐miR‐17 Oligonucleotide RGLS4326 in Healthy Adult Subjects
by: Tate Owen, et al.
Published: (2026)

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults
by: Fangfang Wang, et al.
Published: (2025)